Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a smarter breathing machine boost survival after cardiac arrest?

NCT ID NCT06836908

Completed Knowledge-focused Sponsor: Medical University of Vienna Source: ClinicalTrials.gov ↗

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study tests a new way of delivering breaths during CPR called chest compression synchronized ventilation (CCSV), which times each breath to occur between chest compressions. Researchers will compare it to standard ventilation in 50 adults who suffer cardiac arrest outside the hospital in Vienna. The goal is to see whether CCSV improves oxygen levels, blood flow to the brain, and 30-day survival.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
chest compression synchronized ventilation (CCSV)
What this could lead to
If CCSV proves better, it could become a new standard ventilation method during CPR, potentially improving survival and brain function after cardiac arrest.
What could go wrong
This is a small, early exploratory study in one city, so results may not apply broadly. The intervention is complex and may not show clear benefit over standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC ARREST are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiac arrest

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIAC ARREST

Contacts and locations

Locations

  • Medical University of Vienna

    Vienna, 1090, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.